%PDF-1.4
%
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
10 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
12 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
11 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
14 0 obj
<>stream
application/pdf10.1080/2162402X.2016.1195535application/pdf10.1080/2162402X.2016.1195535enTaylor & Francis
OncoImmunology, 2016. doi:10.1080/2162402X.2016.1195535
Acute myeloid leukemiagalectin-9Tim-3
The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
Isabel Gonçalves SilvaLaura RüeggBernhard F. GibbsMarco BardelliAlexander FruehwirthLuca VaraniSteffen M. BergerElizaveta Fasler-KanVadim V. Sumbayev
10.1080/2162402X.2016.1195535http://dx.doi.org/10.1080/2162402X.2016.11955352016-06-29truewww.tandfonline.com10.1080/2162402X.2016.1195535www.tandfonline.comtrue2016-06-2910.1080/2162402X.2016.1195535application/pdf10.1080/2162402X.2016.1195535enTaylor & Francis
OncoImmunology, 2016. doi:10.1080/2162402X.2016.1195535
Acute myeloid leukemiagalectin-9Tim-3
The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
Isabel Gonçalves SilvaLaura RüeggBernhard F. GibbsMarco BardelliAlexander FruehwirthLuca VaraniSteffen M. BergerElizaveta Fasler-KanVadim V. Sumbayev
JournalOncoImmunologyCopyright Taylor & Francis2162-402X5711110.1080/2162402X.2016.1195535http://dx.doi.org/10.1080/2162402X.2016.1195535
2016-08-10T07:44:04+05:30Arbortext Advanced Print Publisher 10.0.1062/W Unicode2017-01-31T07:01:26-08:002017-01-31T07:01:26-08:00
iText 4.2.0 by 1T3XTAcute myeloid leukemia,galectin-9,Tim-3
uuid:4d9b4421-ead5-4a4d-8eb9-a0e772f7e07fuuid:acf16b53-4505-4868-9603-f1390d028d5e
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS*
R
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi y+
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 Bi y,
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
29 0 obj
<>stream
x+ |
endstream
endobj
30 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
33 0 obj
<>stream
x+ |
endstream
endobj
34 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
35 0 obj
<>stream
x+ |
endstream
endobj
36 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
37 0 obj
<>stream
x+ |
endstream
endobj
38 0 obj
<>stream
xS**T0T0 Bih lT
endstream
endobj
40 0 obj
<>stream
x[I_Ms_`!e;Ǝ'OUdw"c$5^w,ίۃY4sJ-6/GA/?N/_{}F9K 9,N+|)E6gȗneV]5hm%V[꯷21l's_/O}bozLEx}fvyA-ީ`-efc/